Immunology

Monoclonal antibody reduces asthma attacks in urban youth

A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...

Medications

Drug combination reduces the risk of asthma attacks

A global study of asthma patients by Rutgers and an international team of researchers found a combination of two drugs dramatically reduces the chances of suffering an asthma attack.

Diseases, Conditions, Syndromes

Pulmonologist offers tips to manage asthma

Asthma is a condition where airways narrow and swell, possibly producing extra mucus and other symptoms. While asthma affect adults, it's the most common long-term disease in children. More than 262 million people globally ...

page 1 from 21